News Focus
News Focus
Followers 142
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Cardiologymd post# 197030

Tuesday, 06/18/2019 5:36:26 AM

Tuesday, June 18, 2019 5:36:26 AM

Post# of 447690

You obviously have no experience how prescribing to real patients work and what factors influence whether patients fill prescriptions or not.

Yes, you are right … but I did not say otherwise. (Furthermore, I did not post / opine in this area … in any area where I do not have knowledge … unlike you.) However it not the topic … just a reminder: it is the "coverage"

All Vascepa reps have extensive knowledge which insurances cover well and which ones don’t. They are there on the ground.

His 90 percent lives covered is bs that he has to promote to amarin investors.

You obviously have no experience top of how prescribing to real patients work and what factors influence whether patients fill prescriptions or not … your view does not make any sense

- if it is a bs … it is a law / SEC violation … but it isn't a bs
- unless they would like to raise additional cash - which is not likely - the daily pps / investors' opinion has 0.00% effect on the company … he does not have to promote the coverage …
-acc. to my best knowledge the Managed Markets Insight & Technology, LLC is independent from Amarin … says (Medicare): 96% Covered (inc. 18% Preferred) and 4% Not Covered by the 1,476 Medicare plans … and 95% have Unrestricted Access. [Part D plans: app. 44 million … 15% of the US]

"There are some things money can't buy. For everything else, there's AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News